Blood Banking and Blood Products: Market Research Report

Date: January 10, 2015
Pages: 553
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B35D2616800EN
Leaflet:

Download PDF Leaflet

Blood Banking and Blood Products: Market Research Report
This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Group/Types: Blood Components and Plasma Products (Whole Blood & Cellular Components; and Plasma Fractions), and Equipment, Blood Tests and Other Consumables. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 235 companies including many key and niche players such as -
  • AABB
  • Americas Blood Centers
  • American Red Cross
  • Canadian Blood Services
  • Japan Red Cross Society
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Blood Components and Plasma Products
Whole Blood & Cellular Components
WBCs
RBCs
Platelets
Plasma Fractions
Fresh Frozen Plasma
Albumin Fractions
Factor VIII
Factor IX and Factor IX Complex
Fibrin/Thrombin
Equipment, Blood Tests and Consumables
Automated Analyzers for Blood Analysis
Blood Test Consumables

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Prelude
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts
Safety and Availability: The Core Issues

Table 1. Prevalence of Major Transfusion-transmitted Infections by Economic Group (H2 2014): Percentage of HIV, HBV and HCV in High Income, Middle-income and Low Income Countries (includes corresponding Graph/Chart)


Current and Future Analysis
Analysis of World Blood Banking & Blood Products by Value Sales
Analysis by Geographic Region
Analysis by Product Group/Type
Plasma and Plasma Derivatives Continue to Dominate Blood Components Market

Table 2. Global Plasma Derivatives Market by Product (2015E & 2017P): Percentage Breakdown of Consumption Value for Albumin, Alpha-1, FVIII, IVIg, and Others (includes corresponding Graph/Chart)


Equipment, Blood Tests & Other Consumables to Display Steady Growth
World Blood Components and Plasma Market Analysis

Table 3. World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 4. World 7-Year Perspective for Blood Components and Plasma by Region/ Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2014, 2015 & 2020 (includes corresponding Graph/Chart)


Red Blood Cells – A Key Blood Component

Table 5. World Recent Past, Current & Future Analysis for Red Blood Cells by Region/ Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 6. World 7-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2014, 2015 & 2020 (includes corresponding Graph/Chart)

2. MARKET TRENDS & ISSUES

Blood Plasma Demand Exceeds Supply: Self-Sufficiency is the New Mantra
Manufacturers Step Up Production Capacity to Meet Growing Demand for Plasma Derivative Products
Platelet Rich Plasma Therapy Market Scales New Heights
Increasing Awareness of PID and CIPD Disorders to Drive IVIg Market
Indications Addressed by Major Global IVIg Manufacturers

Table 7. Comparative Costs between Plasma Protein Therapies and Artificially Synthesized Pharmaceuticals (includes corresponding Graph/Chart)


Growing Affinity for Home Care Unlocks Opportunities for Home-based IVIg Therapy

Table 8. Worldwide Home Healthcare Services Market by Type of Service (2015E & 2020P): Percentage Breakdown of Service Revenues for Infusion Therapy Services, Rehabilitation Services, Respiratory Therapy Services, Telemetry, and Unskilled Homecare (includes corresponding Graph/Chart)


Unsuccessful Clinical Trials for Alzheimer’s a major Setback for IVIg Market
Huge Under-Diagnosed Pool of AAT Patients Highlights High Potential for Alpha-1 Protein
Rising Incidence of Cancer Drives Demand for Apheresis Systems
PrIME: An Innovative High-Yield Process to Address Supply Dearth
Present State of Plasma Fractionating Industry
Plasma Fractionation Industry Concentrated in Developed Countries
PrIME Tackles the Issue of Currently Unprocessable Plasma
Industry Grappling with Blood Safety & Availability Issues
New Infections – A Continuous Threat
Synthetic Substitutes to Bridge Demand-Supply Gap in Blood
Autologous Transfusion Gearing up for High Growth
Out-of-Hospital Transfusions: An Emerging Phenomenon
Automation Tapping into Blood Market
Automated in Pre-Transfusion Diagnostics
Penetration of Automated Equipment in the Plasma Market
The Red Blood Cell Collection Opportunity
Robots in Blood Banking
Blood Banks Switching from Manual to Automated Cooler Validation
Automated Blood Processing Systems in Open Heart Surgeries
Automated Systems in Cancer
Pooling: Economical HIV Testing
Ballooning Global Geriatric Populace to Drive Demand for Blood Products`

Table 9. Elderly Population (65+ Years) as a Percentage of the Total Population: 2014 & 2025 (includes corresponding Graph/Chart)
Table 10. Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)


Improving Healthcare Expenditure to Foster Growth of Blood Banking Sector

Table 11. Global Intravenous Immunoglobulin Consumption in Kilograms per Million Residents for Select Countries (includes corresponding Graph/Chart)
Table 12. Per-Capita Healthcare Expenditure in US$ for Select Regions (2014) (includes corresponding Graph/Chart)

3. COMPETITIVE LANDSCAPE

Leaders in Global Blood Plasma Ramp Up Market Share

Table 13. Global Plasma Fractionation Capacity by Leading Producers (2016 & 2020): Percentage Breakdown of Production Capacity for Baxter, Biotest, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)


IVIg – A Highly Consolidated Market

Table 14. Global Market for Immunoglobulin (IVIg and SCIg) by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
Table 15. Global IVIg Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)


Select IVIg Products Offered by Global Leading Players

Table 16. Global Subcutaneous Immunoglobulin Market by Leading Player (2014): Percentage Market Share Breakdown of Revenue for Baxter, CSL, and Grifols (includes corresponding Graph/Chart)


Big Three Corner Majority of Blood Collection Systems Market

Table 17. Global Whole Blood Collection Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, MacoPharma, Terumo, WEGO, and Others (includes corresponding Graph/Chart)
Table 18. Global Apheresis Systems Market (2015E): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)


Key Statistics

Table 19. Global Human Albumin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, Octapharma, and Others (includes corresponding Graph/Chart)
Table 20. Global Plasma-Derived Factor VIII Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, Biotest, CSL, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
Table 21. Global Alpha-1 Market by Leading Players (2014): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart)
Table 22. Global In-Vitro Diagnostics Instruments, Reagents & Supplies Market by Leading Players (2015E): Percentage Breakdown of Value Sales for Abbott, bioMerieux, Danaher, Johnson & Johnson, Roche, Siemens, and Others (includes corresponding Graph/Chart)
Table 23. Global Molecular Diagnostics Instruments, Reagents & Supplies Market by Leading Players (2015E): Percentage Breakdown of Value Sales for Abbott, Becton Dickinson, Gen-Probe/Hologic, Novartis, Qiagen, Roche, and Others (includes corresponding Graph/Chart)

4. PRODUCT OVERVIEW

Blood Banking and Blood Products Industry
Blood Components and Plasma Products
Equipment, Blood Tests and Consumables
Automated Analyzers for Blood Analysis
Blood Tests
Consumables
Blood Collection Equipment
Blood Collection Monitors
Blood Donor Couches
Blood Processing Equipment
Blood Bank Centrifuges
Plasma Thawing
Blood Cell Separators
Blood Storage Equipment
Blood Bags
Platelet Agitators
Blood Bank Refrigerators
Blood – A Primer
Ionic Structure
Blood Components and their Applications
Blood Constituents
Plasma
Red Blood Cells (RBC)
Blood Count
Platelets
White Blood Cells (WBC)
Derivative Products of Blood or Plasma Fractions
Albumin Fractions
Immunoglobulins
Hyper-Immune Immunoglobulin
Factor VIII
Factor IX and Factor IX Complex
Fibrin/Thrombin
Consumption of Blood Based on Type of Surgery/Accident (In Units)

Table 24. Worldwide Market for Plasma Derivative Products by Product Type (2014): Percentage Breakdown of Revenue Sales for A1PI, Albumin, Coagulation Factor, Hyperimmunes, IVIG, Plasma Derived Factor VIII, Prothrombin Complex Concentrate, and Others (includes corresponding Graph/Chart)


Recombinant Products
Development Pipeline of Select rFVIII Products Developed for Hemophilia Therapy
Blood Plasma Sourcing

Table 25. Global Plasma Derivatives Market: Percentage Breakdown of Costs Associated with Production (includes corresponding Graph/Chart)


Plasma Protein and Fractionation
Plasma Fractionation: Origins and Development

Table 26. Plasma Fractionation Processes: Comparison of Cohn IVIG and PrIME IVIG Based on Specific Characteristics


The Need
Fresh Frozen Plasma
Other Plasma Fractions
IVIG
Factor VIII
Albumin
Therapeutic Uses of Plasma Products
Albumin Products
Immunoglobulins
Intravenous Immunoglobulin (IVIg)
Normal Immunoglobulin (IMIg)
CMV Immunoglobulin
Hepatitis B Immunoglobulin
Rh (D) Immunoglobulin
Tetanus Immunoglobulin IM
Zoster Immunoglobulin
Plasma Derived Coagulant Products
Biostate
Ceprotin
Factor VII Concentrate
Factor XI Concentrates
Feiba VH Inhibitor Treatment
Fibrogammin P
Monofix-VF
ProthrombinexTM-HT
Thrombotrol-VF

5. BLOOD COLLECTION METHODS

Banking the Natural Blood Resources
Blood Banks
Blood Banking
Blood Transfusion
Role of Blood Banks
Blood Donor: The Epicenter of the Process
Eligibility Criteria for the Donor
The Basics of Blood Donation – Myths & Facts

Table 27. Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/ Agency (includes corresponding Graph/Chart)
Table 28. Percentage Breakdown of Apheresis and Whole Blood Donations by Country (includes corresponding Graph/Chart)


Collection Methods
Blood Donation: The Process
Types of Blood Donation
Directed Blood Donations
Autologous Blood Donation
Alternative Usage of Patient’s Own Blood
General Blood Donation
Hemodilution
Wound Drainage
Cell Saver
The Method
Blood Salvaging
Blood Collection Centers
Blood Collection Management System
A Historical Retrospective
Blood Collection Centers
Types of Blood Collection Centers
Cord Blood Banks
Profit Collection Centers
Military Blood Banks
Hospital Blood Banks
Community Blood Banks
Non-Profit Collection Centers
Blood Processing
Blood Typing
Rh Blood Group System
ABO Blood Group System
Blood Types and their Compatibility

Table 29. Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart)


Blood Test
Blood Culture
The Costs
History of Blood Banking

6. THE DYNAMIC LANDSCAPE OF TRANSFUSION TECHNOLOGIES & TESTS

Blood Transfusion: A Backdrop
Massive Transfusion
Complications and Risks Due to Transfusion
Circulatory Overload
Graft Versus Host Disease (GVHD)
Hemolytic Transfusion Reactions
Iron Overload
Bacterial Contamination
Thrombophlebitis
Allergic Reactions
Air Embolism
Hyperkalaemia
Changing Role of Blood Banking Technology

7. BLOOD TRANSFUSION: THE PROCESS, TESTS/TECHNOLOGIES

Cross Matching
Blood Donor/Recipient Screening
Blood Typing
Leukoreduction
Leukocyte Reduction Specification Standards/Filters
Coombs Test

8. ALTERNATIVES TO BLOOD TRANSFUSION: A REAL THREAT TO THE INDUSTRY

Bloodless Surgery
Therapeutic Apheresis
Plasmapheresis
Plateletpheresis
Leukapheresis
Volume Expanders
Colloids
Albumin
Dextrans
Hydroxyethyl Starch
Crystalloids
Blood Growth Factor Therapies – Newer Alternatives to Transfusion

9. RECENT INDUSTRY ACTIVITY

OneBlood to Merge with The Blood Alliance
Cerus Corporation Inks Purchase Agreement with Karolinska University Hospital
Cerus Corporation Signs Purchase Agreement with Blood Bank of Delmarva
Canadian Blood Services Closes 3 Permanent Clinics, Terminates Bloodmobile Program
Roche Releases Elecsys HTLV-I/II Immunoassay
Roche Receives USFDA Approval for cobas TaqScreen MPX Test v2. 0 for HIV, HCV, and HBV Tests
China Biologic Products Purchases Additional Stake in Guizhou Taibang Biological Products
Community Blood Center Merges with New York Blood Center
Cerus Corp. Partners with Kawasumi Laboratories for Developing Intercept Platelets Kits
Vascular Solutions Collaborates with US AMMDA to Develop Plasma Products for Treating Hemorrhage
The San Diego Blood Bank Collaborates with Clinical and Translational Research Institute
Affinity Biologicals Unveils Factor VIII Deficient, Factor IX Deficient Plasmas
AABB Collaborates with AATM for Promoting Blood and Cellular Therapies Standards in Asia
bioCSL Partners with Immucor for Distributing Transfusion Technology in Australia and New Zealand
PrIME Biologics Opens Plasma Fractionation Plant in Singapore
Terumo BCT Acquires Medservice
Grifols Acquires Transfusion Diagnostics Unit of Novartis
Lab21 Divests Blood Bank Screening, Molecular Assets to Trinity Biotech
New York Blood Center Acquires Coral Blood Services
Entegrion Inks Licensing Agreement with Kedrion Melville for Developing Resusix
Davao del Norte Opens New Blood Banking Facility

10. FOCUS ON SELECT GLOBAL PLAYERS

Leading Blood Banks
AABB (USA)
America’s Blood Centers (USA)
American Red Cross (USA)
Canadian Blood Services (Canada)
Japan Red Cross Society (Japan)
New York Blood Center (USA)
Sanquin Blood Supply Foundation (The Netherlands)
Leading Players in Blood Bank Technology and Supplies
Abbott Diagnostics, Inc. (USA)
Beckman Coulter, Inc. (USA)
Becton, Dickinson and Company (USA)
bioMerieux SA (France)
Bio-Rad Laboratories, Inc. (USA)
Cerus Corporation (USA)
CSL Behring LLC (USA)
Fresenius Kabi AG (Germany)
Fenwal Inc. (USA)
Gen-Probe, Inc. (USA)
Haemonetics Corporation (USA)
Immucor Inc. (USA)
Kawasumi Laboratories, Inc. (Japan)
MacoPharma SA (France)
Ortho-Clinical Diagnostics, Inc. (USA)
Terumo BCT Inc. (USA)
Leading Players in Plasma Fractionation
Baxter International Inc. (USA)
Beijing Tiantan Biological Products Co., Ltd (China)
Bharat Serums and Vaccines Ltd (India)
Bio Products Laboratory Ltd (UK)
Biotest AG (Germany)
China Biologic Products, Inc. (China)
Grifols S. A. (Spain)
Huanlan Biological Engineering Inc. (China)
Kedrion S. p. A. (Italy)
LFB Group (France)
Octapharma AG (Switzerland)
OMRIX Biopharmaceuticals Ltd (Israel)
Shanghai RAAS Blood Products Co., Ltd. (China)
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)

11. GLOBAL MARKET PERSPECTIVE

Table 30. World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 31. World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 32. World 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)


Blood Banking and Blood Products Market by Product Group/Type

Table 33. World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 34. World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 35. World 14-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 36. World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 37. World Historic Review for Blood Components and Plasma Products by Product Type - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 38. World 14-Year Perspective for Blood Components and Plasma Products by Product Type - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 39. World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 40. World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 41. World 14-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 42. World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 43. World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 44. World 14-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 45. World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 46. World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 47. World 14-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Current and Future Analysis
Demand for Blood Transfusion Continues to Wane

Table 48. US Blood and Organ Banks by Leading Players (2014): Percentage Share Breakdown of Revenues for American Red Cross, Baxter International Inc., Blood Systems, Musculoskeletal Transplant Foundation, New York Blood Center, and Others (includes corresponding Graph/Chart)
Table 49. US Blood Banking Market by Leading Suppliers (2015): Percentage Breakdown of Unit Volumes for American Red Cross, Blood Centers of America, and Others (includes corresponding Graph/Chart)
Table 50. American Red Cross Dominates US Blood Platelet Production (2014): Percentage Share Breakdown of Production Volume for American Red Cross, and Others (includes corresponding Graph/Chart)


Aging Baby-Boomer Demography: A Key Market Driver

Table 51. North American Elderly Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)


Favorable Reimbursement and High Usage Make US the Largest Consumer of Immunoglobulins Worldwide
Recession Impacts Blood Bank Reserves
US Blood Collection & Supply Profile
Blood Group Distribution

Table 52. US Market for Blood Banking and Blood Products: Percentage Breakup of Blood Group by Rh Factor (includes corresponding Graph/Chart)
Table 53. Percentage Breakup of Rh Blood Types in the US by Racial Group (includes corresponding Graph/Chart)


US Plasma Industry Remains Highly Concentrated

Table 54. US Plasma Derivatives Market by Leading Suppliers (2015): Percentage Breakdown of Value Sales for Baxter, CSL, Grifols, and Others (includes corresponding Graph/Chart)
Table 55. US Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, CSL Ltd., Grifols, and Others (includes corresponding Graph/Chart)
Table 56. US Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales for Baxter, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)
Table 57. US Market for Immunoglobulin by Leading Players (2014): Percentage Breakdown of Value Sales for Gammagard Liquid/Kiovig, Flebogamma/Gamunex, Privigen/Carimune NF, Octagam and Others (includes corresponding Graph/Chart)
Table 58. US Market for IVIg Products by Indication (2014 & 2020P): Percentage Breakdown of Volume Sales for CIDP, CLL, ITP, MMN, PID, and Other Neurological Diseases (includes corresponding Graph/Chart)
Table 59. US Specific Immunoglobulin Market by Product Type (2014): Percentage Breakdown of Value Sales for Anti-D, Anti-HB, Anti-T, and Rabies Immunoglobulin (includes corresponding Graph/Chart)
Table 60. US Specific Immunoglobulin Market by Leading Players (2014): Percentage Breakdown of Value Sales for Biotest, Cangene, CSL, Grifols, Kedrion, Sanofi (includes corresponding Graph/Chart)


Changing Supply Dynamics Alters Economics of Plasma Production

Table 61. Average Price per Gram of IVIg for Europe and US Markets (includes corresponding Graph/Chart)


Regulations Control Plasma Collection Industry
Key Statistics

Table 62. US Blood Bag (With Filters) Market (2014): Percentage Share Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)
Table 63. US Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)
Table 64. US Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/ Fenwal, Haemonetics, and Terumo (includes corresponding Graph/Chart)


Strategic Corporate Activity
Select Key Players
B. Market Analytics
US Blood Components and Plasma Market Analyzed by Value Sales

Table 65. US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 66. US Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 67. US 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)


US Blood Components and Plasma Market Analyzed by Consumption in Units

Table 68. US Recent Past, Current & Future Analysis for Blood Components and Plasma by Blood Components- Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 69. US Historic Review for Blood Components and Plasma by Blood Components - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 70. US 14-Year Perspective for Blood Components and Plasma by Blood Components - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Current and Future Analysis
Bleeding Disorders – A Major Threat
'CSA-Z902-04' – A Comprehensive Voluntary Blood Safety Standard
Strategic Corporate Developments
Canadian Blood Services – The Major Blood Bank
B. Market Analytics

Table 71. Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 72. Canadian Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 73. Canadian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis
Current and Future Analysis
Japan Witnesses Surge in Imported Blood Products
Growing Market for Fresh Frozen Plasma
Growing Use of Imported Albumin Based Blood Products
The Goal of Self-Sufficiency
Graying Population to Drive Market Growth

Table 74. Japanese Elderly (65+ Years) Population for the Period 2000-2020 (includes corresponding Graph/Chart)


Corporate Development
Select Players
B. Market Analytics

Table 75. Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 76. Japanese Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 77. Japanese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

A. Market Analysis
Current and Future Analysis
Market Trends and Issues
Legislations on Payment for Donation Restrict Donors
Government’s Check on Healthcare Costs Pressurizes BCT Manufacturers
Purchasing System Witnesses Modifications
Aging Population to Drive Demand for IVIg Products

Table 78. Aging Population in Europe by Geographic Region (2015E & 2020): Percentage of Elderly Individuals of Age 60 Years and Above Compared to Overall Population for Eastern Europe, Northern Europe, Southern Europe, and Western Europe (includes corresponding Graph/Chart)
Table 79. European Market for Intravenous Immunoglobulin by Leading Player (2014): Percentage Market Share Breakdown of Volume Sales by Plasma Fractionators for Baxter Healthcare, Biotest, CSL Behring, Grifols, Kedrion, Octapharma, and Others (includes corresponding Graph/Chart)


Overview of Blood Banking Market

Table 80. European Blood Bag Market (2014E): Percentage Breakdown of Value Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo and Others (includes corresponding Graph/Chart)
Table 81. European Whole Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, MacoPharma, Terumo, and Others (includes corresponding Graph/Chart)
Table 82. European Automated Blood Collection Market (2014): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart)


B. Market Analytics

Table 83. European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 84. European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 85. European 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 86. European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 87. European Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 88. European 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4A. FRANCE

A. Market Analysis
Current and Future Analysis
Key Players
B. Market Analytics

Table 89. French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 90. French Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 91. French 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4B. GERMANY

A. Market Analysis
Current and Future Analysis
Select Players
B. Market Analytics

Table 92. German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 93. German Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 94. German 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4C. ITALY

A. Market Analysis
Current and Future Analysis
Kedrion S. P. A. – A Leading Italian Player for Plasma Fractionation
B. Market Analytics

Table 95. Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 96. Italian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 97. Italian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4D. THE UNITED KINGDOM

A. Market Analysis
Current and Future Analysis
Bio Products Laboratory Ltd – A Leading UK Player for Plasma Fractionation
B. Market Analytics

Table 98. UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 99. UK Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 100. UK 14-Year Perspective for Blood Banking and Blood Products by Product Group/ Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4E. SPAIN

A. Market Analysis
Current and Future Analysis
Grifols, S. A – A Leading Spanish Player for Plasma Fractionation
B. Market Analytics

Table 101. Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 102. Spanish Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 103. Spanish 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4F. RUSSIA

Market Analysis

Table 104. Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020(includes corresponding Graph/Chart)
Table 105. Russian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 106. Russian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4G. REST OF EUROPE

A. Market Analysis
Current and Future Analysis
Denmark – High Participation and Consumption of Blood
Strategic Corporate Developments
Select Players
B. Market Analytics

Table 107. Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 108. Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 109. Rest of Europe 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis

Table 110. Asia-Pacific Whole Blood Collection Market (2014E): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Weigao, and Others (includes corresponding Graph/Chart)
Table 111. Asia-Pacific Automated Blood Collection Market (2014E): Percentage Share Breakdown of Volume Sales for Leading Companies - Fresenius/Fenwal, Haemonetics, Terumo and Others (includes corresponding Graph/Chart)


ASEAN – Striding Towards Standardization of Blood Supply
B. Market Analytics

Table 112. Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 113. Asia-Pacific Historic Review for Blood Banking and Blood Products by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 114. Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for China, and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 115. Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 116. Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 117. Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5A. CHINA

A. Market Analysis
A Key Market
Government Wakes Up to Realities

Table 118. Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart)
Table 119. Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female (includes corresponding Graph/Chart)
Table 120. Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes corresponding Graph/Chart)


Overview of Chinese Blood Plasma Market

Table 121. Chinese Blood Products Demand by Type of Product (2014): Percentage Breakdown of Lot Release Volumes for Human IVIG, Human Albumin, Human Rabies Ig, Human Tetanus Ig, and Others (includes corresponding Graph/Chart)


Availability of Plasma Proteins in the US and China (2015): A Comparison

Table 122. Chinese Plasma Based Products Market by Product Type (2015 & 2020P): Percentage Breakdown of Value Sales for Human Albumin, Human IVIg, and Others (includes corresponding Graph/Chart)


Government Exercises Strict Control Over Production, Supply and Import of Plasma- based Products
Gap in Domestic Demand and Supply of Plasma Products Persists Despite Increasing Output

Table 123. Plasma Supply, Demand, and Deficit in Chinese Market: 2008-2014 (includes corresponding Graph/Chart)
Table 124. Rising Number of Plasma Collection Stations and Volume of Plasma Collection in China: 2018-2014 (includes corresponding Graph/Chart)


Comparison of Average Yields for Select Plasma Based Products in China and International Markets
Deregulation and Supply Crunch to Drive Up Retail Prices of Plasma-based Products
Expanding Medical Indications Holds Key to Boosting Market Growth
Comparison of USFDA and CFDA Approved Indications for Human Albumin Therapeutic Products
Comparison of USFDA and CFDA Approved Indications for Human IVIG Therapeutic Products
Competitive Landscape

Table 125. Chinese Plasma Collection Stations Market by Leading Players (2014): Percentage Breakdown of Stations Owned by China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)


Blood Plasma Product Portfolio of Major Domestic Players

Table 126. Chinese Plasma Collection Market by Leading Players (2014): Percentage Volume Breakdown of Plasma Collection for Anhui Tonglu, CBPO, Chengdu Rongsheng, Hualan Biological, Shanxi Kangbao, Sichuan Shuyang, and Others (includes corresponding Graph/Chart)


Albumin Market in China Gains Favor of both Global and Local Players

Table 127. Chinese Human Albumin Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Baxter Healthcare, China Biologic (CBPO), CNBG Shanghai Institute, CSL Behring, Grifols International, Octapharma, Shanghai RAAS, and Others (includes corresponding Graph/Chart)


Key Statistics

Table 128. Chinese IVIG (Intravenous Immunoglobulin) Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)
Table 129. Chinese Coagulation Factor VIII Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), Greencross China, Hualan Biological, and Shanghai RAAS (includes corresponding Graph/Chart)
Table 130. Chinese Hepatitis B Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Hunan Nanyue, Shenzhen Weiwu, Sichuan Yuanda Shuyang, and Others (includes corresponding Graph/Chart)
Table 131. Chinese Rabies Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Guangdong Shuanglin Bio-Pharmacy, Hualan Biological, Hunan Nanyue, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)
Table 132. Chinese Tetanus Ig Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Anhui Tonrol, China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)
Table 133. Chinese Human PCC (Prothrombin Complex Concentrate) Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, and Others (includes corresponding Graph/Chart)
Table 134. Chinese Human Ig Market by Leading Players (2014): Percentage Breakdown of Volume Sales for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, and Sichuan Yuanda Shuyang Pharmaceutical (includes corresponding Graph/Chart)
Table 135. Chinese Human Fibrinogen Products Market by Leading Players (2014): Percentage Breakdown of Volume Sales for Hualan Biological, Jiangxi Boya Bio-Pharmaceutical, Shanghai RAAS, and Others (includes corresponding Graph/Chart)
Table 136. Chinese Plasma Collection Market by Leading Players (2014): Percentage Breakdown of Plasma Collection Volume for Anhui Tonglu, Chengdu Rongsheng Pharmaceutical, China Biologic (CBPO), Hualan Biological, Shanxi Kangbao Biological, Sichuan Yuanda Shuyang Pharmaceutical, and Others (includes corresponding Graph/Chart)
Table 137. Chinese Plasma Market by Leading Players (2014): Percentage Breakdown of Plasma Output Volume for China Biologic (CBPO), CNBG Shanghai Institute, Hualan Biological, Shanghai RAAS, and Others (includes corresponding Graph/Chart)
Table 138. Leading Companies in the Chinese Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius, Shanghai Kindly Enterprise Development Group, Terumo, WEGO and Others (includes corresponding Graph/Chart)


Strategic Corpoate Development
Select Key Players
B. Market Analytics

Table 139. Chinese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 140. Chinese Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 141. Chinese 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5B. REST OF ASIA-PACIFIC

A. Market Analysis
Current and Future Analysis
Overview of Select Regional Markets
Australia
National Blood Supply: An Overview
Role of National Blood Authority
Maintenance Expenditure on the Rise
India
Demand for Blood Banking Equipment Market on the Rise
Recent Trends in the Market
Indian Blood Banking Market Witnesses Major Transformations
Market Growth – Influencing Factors
Increased Awareness Drives Voluntary Blood Donations in India
Competitive Scenario
Indonesia
Strategic Corporate Developments
Bharat Serums and Vaccines Ltd. – A Leading Indian Player for Plasma Fractionation
B. Market Analytics

Table 142. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 143. Rest of Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 144. Rest of Asia-Pacific 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

A. Market Analysis
Current and Future Analysis

Table 145. Leading Companies in the Latin American Whole Blood Processing Market (2014): Percentage Breakdown of Volume Sales for Fresenius/Fenwal, Grifols, JP, Terumo and Others (includes corresponding Graph/Chart)


B. Market Analytics

Table 146. Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 147. Latin American Historic Review for Blood Banking and Blood Products by Geographic Region - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 148. Latin American 14-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for Brazil, and Rest of Latin America Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
Table 149. Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 150. Latin American Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 151. Latin American 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6A. BRAZIL

Market Analysis

Table 152. Brazilian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 153. Brazilian Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 154. Brazilian 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6B. REST OF LATIN AMERICA

Market Analysis

Table 155. Rest of Latin America Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 156. Rest of Latin America Historic Review for Blood Banking and Blood Products by Product Group/ Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 157. Rest of Latin America 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

A. Market Analysis
Current and Future Analysis
Omrix Biopharmaceuticals Ltd (Israel) - A Leading Plasma Fractionation Player
B. Market Analytics

Table 158. Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
Table 159. Rest of World Historic Review for Blood Banking and Blood Products by Product Group/Type - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
Table 160. Rest of World 14-Year Perspective for Blood Banking and Blood Products by Product Group/Type - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 235 (including Divisions/Subsidiaries - 273)
The United States (128)
Canada (10)
Japan (12)
Europe (53)
  France (4)
  Germany (16)
  The United Kingdom (12)
  Italy (4)
  Spain (3)
  Rest of Europe (14)
Asia-Pacific (Excluding Japan) (63)
Latin America (3)
Africa (2)
Middle East (2)
Skip to top


Ask Your Question

Blood Banking and Blood Products: Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: